Contact this trialFirst, we need to learn more about you.
Alkylating agents
Chemotherapy + Pomalidomide for HIV-Associated Lymphoma
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial tests a combination of pomalidomide and chemotherapy, with or without rituximab, in adults with HIV and high-risk B-cell non-Hodgkin lymphoma. Pomalidomide boosts the immune system and helps increase important immune cells. The goal is to find the safest and most effective dose for this treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service